ARCHIVES

Vaccine and LDCT Pretreatment Can Help PDACs Become Vulnerable to Immunotherapy

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

May 4, 2001

2015 Goal Not a Dream, But a Vision, Director Says

July 18, 2003

Watson Steps Down As Chancellor at Cold Spring Harbor Laboratory.

October 26, 2007

ACS Cancer Control Research Grant Programs Available

May 5, 2000

Upton Leaning to New Division for Centers, Organ Sites, Education

August 25, 1978

EORTC Screening, Pharmacology Group Focuses On CNU

January 2, 1987